Enthusiasm appears to be coming back into the market on the back of Bitcoin’s recent surge, and it’s now time for traders to re-evaluate the coins that belong in their cryptocurrency portfolio. A powerful influencer on Twitter recently posted that the current environment feels a lot like 2017 in that micro caps may be setting up for a powerful bull run. During the past year, I’ve written a lot about the potential that Encrypgen (DNA) has. And while many other companies have disappointed their token hodlers, Encrypgen continues to demonstrate why its platform will stand the test of time. As new money continues to come rushing into the market, and Encrypgen continues to exceed expectations, there is no doubt that the DNA token belongs in your portfolio!
Major Milestone Achieved
Encrypgen’s team, led by David Koepsell, recently announced that the final functionality was completed for the Gene-Chain. This means that anyone can use their ERC20 DNA tokens to buy and sell data. Thus far, there have been more than…